Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Danielle Majoor-Krakauer is active.

Publication


Featured researches published by Danielle Majoor-Krakauer.


Jacc-cardiovascular Imaging | 2009

Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations.

Michelle Michels; Osama Ibrahim Ibrahim Soliman; Marcel Kofflard; Yvonne Hoedemaekers; Dennis Dooijes; Danielle Majoor-Krakauer; Folkert J. ten Cate

OBJECTIVESnTo test the hypothesis that carriers of Dutch founder mutations in cardiac myosin-binding protein C (MYBPC3), without left ventricular hypertrophy (LVH) or electrocardiographic abnormalities, have diastolic dysfunction on tissue Doppler imaging (TDI), which can be used for the screening of family members in the hypertrophic cardiomyopathy (HCM) population.nnnBACKGROUNDnTDI is a more sensitive technique for the assessment of left ventricular contraction and relaxation abnormalities than is conventional echocardiography.nnnMETHODSnEchocardiographic studies including TDI were performed in genotyped hypertrophic cardiomyopathy patients (genotype-positive, G+/LVH+; n = 27), mutation carriers without LVH (G+/LVH-; n = 27), and healthy controls (n = 55). The identified mutations in MYBPC3 in the G+/LVH+ subjects were c.2864_2865delCT (12 subjects), c.2373dupG (n = 8), and p. Arg943X (n = 7). In the G+/LVH- subjects, the following mutations were identified: c.2864_2865delCT (n = 11), c.2373dupG (n = 8), and p. Arg943X (n = 8).nnnRESULTSnMean TDI-derived systolic and early and late diastolic mitral annular velocities were significantly lower in the G+/LVH+ subjects compared with the other groups. However, there was no difference between controls and G+/LVH- subjects. Mean TDI-derived late mitral annular diastolic velocities were significantly higher in the G+/LVH- subjects compared with controls and G+/LVH+ subjects. Using a cut-off value of mean +/- 2 SD, an abnormal late mitral annular diastolic velocity was found in 14 (51%) of G+/LVH- patients. There was no difference among the 3 different mutations.nnnCONCLUSIONSnIn contrast to earlier reports, mean mitral annular systolic velocity and early mitral annular diastolic velocity velocities were not reduced in G+/LVH- subjects, and TDI velocities were not sufficiently sensitive for determination of the affected status of an individual subject. Our findings, however, support the theory that diastolic dysfunction is a primary component of pre-clinical HCM.


Netherlands Heart Journal | 2007

Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience.

Michelle Michels; Yvonne M. Hoedemaekers; Marcel Kofflard; Ingrid M.E. Frohn-Mulder; Dennis Dooijes; Danielle Majoor-Krakauer; F.J. Ten Cate

Hypertrophic cardiomyopathy (HCM) is a disease characterised by unexplained left ventricular hypertrophy (LVH) (i.e. LVH in the absence of another cardiac or systemic disease that could produce a similar degree of hypertrophy), electrical instability and sudden death (SD).Germline mutations in genes encoding for sarcomere proteins are found in more than half of the cases of unexplained LVH. The autosomal dominant inherited forms of HCM are characterised by incomplete penetrance and variability in clinical and echocardiographic features, prognosis and therapeutic modalities. The identification of the genetic defect in one of the HCM genes allows accurate presymptomatic detection of mutation carriers in a family. Cardiac evaluation of at-risk relatives enables early diagnosis and identification of those patients at high risk for SD, which can be the first manifestation of the disease in asymptomatic persons. In this article we present our experience with genetic testing and cardiac screening in our HCM population and give an overview of the current literature available on this subject. (Neth Heart J 2007;15:184-9.)


Journal of Vascular Surgery | 2014

Familial abdominal aortic aneurysm is associated with more complications after endovascular aneurysm repair

Frederico Bastos Gonçalves; Sanne E. Hoeks; Danielle Majoor-Krakauer; Ellen V. Rouwet; Robert Jan Stolker; Hence J.M. Verhagen

OBJECTIVEnA familial predisposition to abdominal aortic aneurysms (AAAs) is present in approximately one-fifth of patients. Nevertheless, the clinical implications of a positive family history are not known. We investigated the risk of aneurysm-related complications after endovascular aneurysm repair (EVAR) for patients with and without a positive family history of AAA.nnnMETHODSnPatients treated with EVAR for intact AAAs in the Erasmus University Medical Center between 2000 and 2012 were included in the study. Family history was obtained by written questionnaire. Familial AAA (fAAA) was defined as patients having at least one first-degree relative affected with aortic aneurysm. The remaining patients were considered sporadic AAA. Cardiovascular risk factors, aneurysm morphology (aneurysm neck, aneurysm sac, and iliac measurements), and follow-up were obtained prospectively. The primary end point was complications after EVAR, a composite of endoleaks, need for secondary interventions, aneurysm sac growth, acute limb ischemia, and postimplantation rupture. Secondary end points were specific components of the primary end point (presence of endoleak, need for secondary intervention, and aneurysm sac growth), aneurysm neck growth, and overall survival. Kaplan-Meier estimates for the primary end point were calculated and compared using log-rank (Mantel-Cox) test of equality. A Cox-regression model was used to calculate the independent risk of complications associated with fAAA.nnnRESULTSnA total of 255 patients were included in the study (88.6% men; age 72 ± 7 years, median follow-up 3.3 years; interquartile range, 2.2-6.1). A total of 51 patients (20.0%) were classified as fAAA. Patients with fAAA were younger (69 vs 72 years; P = .015) and were less likely to have ever smoked (58.8% vs 73.5%; P = .039). Preoperative aneurysm morphology was similar in both groups. Patients with fAAA had significantly more complications after EVAR (35.3% vs 19.1%; P = .013), with a twofold increased risk (adjusted hazard ratio, 2.1; 95% confidence interval, 1.2-3.7). Secondary interventions (39.2% vs 20.1%; P = .004) and aneurysm sac growth (20.8% vs 9.5%; P = .030) were the most important elements accounting for the difference. Furthermore, a trend toward more type I endoleaks during follow-up was observed (15.6% vs 7.4%; P = .063) and no difference in overall survival.nnnCONCLUSIONSnThe current study shows that patients with a familial form of AAA develop more aneurysm-related complications after EVAR, despite similar AAA morphology at baseline. These findings suggest that patients with fAAA form a specific subpopulation and create awareness for a possible increase in the risk of complications after EVAR.


Journal of Vascular Surgery | 2014

Lower atherosclerotic burden in familial abdominal aortic aneurysm.

Frederico Bastos Gonçalves; Sanne E. Hoeks; Tabita M. Valentijn; Robert Jan Stolker; Danielle Majoor-Krakauer; Hence J.M. Verhagen; Ellen V. Rouwet

OBJECTIVEnDespite the apparent familial tendency toward abdominal aortic aneurysm (AAA) formation, the genetic causes and underlying molecular mechanisms are still undefined. In this study, we investigated the association between familial AAA (fAAA) and atherosclerosis.nnnMETHODSnData were collected from a prospective database including AAA patients between 2004 and 2012 in the Erasmus University Medical Center, Rotterdam, The Netherlands. Family history was obtained by written questionnaire (93.1% response rate). Patients were classified as fAAA when at least one affected first-degree relative with an aortic aneurysm was reported. Patients without an affected first-degree relative were classified as sporadic AAA (spAAA). A standardized ultrasound measurement of the common carotid intima-media thickness (CIMT), a marker for generalized atherosclerosis, was routinely performed and patients clinical characteristics (demographics, aneurysm characteristics, cardiovascular comorbidities and risk factors, and medication use) were recorded. Multivariable linear regression analyses were used to assess the mean adjusted difference in CIMT and multivariable logistic regression analysis was used to calculate associations of increased CIMT and clinical characteristics between fAAA and spAAA.nnnRESULTSnA total of 461 AAA patients (85% men, mean age, 70 years) were included in the study; 103 patients (22.3%) were classified as fAAA and 358 patients (77.7%) as spAAA. The mean (standard deviation) CIMT in patients with fAAA was 0.89 (0.24) mm and 1.00 (0.29) mm in patients with spAAA (P = .001). Adjustment for clinical characteristics showed a mean difference in CIMT of 0.09 mm (95% confidence interval, 0.02-0.15; P = .011) between both groups. Increased CIMT, smoking, hypertension, and diabetes mellitus were all less associated with fAAA compared with spAAA.nnnCONCLUSIONSnThe current study shows a lower atherosclerotic burden, as reflected by a lower CIMT, in patients with fAAA compared with patients with spAAA, independent of common atherosclerotic risk factors. These results support the hypothesis that although atherosclerosis is a common underlying feature in patients with aneurysms, atherosclerosis is not the primary driving factor in the development of fAAA.


Human Genetics | 2015

First genetic analysis of aneurysm genes in familial and sporadic abdominal aortic aneurysm

Daphne Heijsman; Alessandra Maugeri; Marjan M. Weiss; Hence J.M. Verhagen; Arne IJpma; Hennie T. Brüggenwirth; Danielle Majoor-Krakauer

Genetic causes for abdominal aortic aneurysm (AAA) have not been identified and the role of genes associated with familial thoracic aneurysms in AAA has not been explored. We analyzed nine genes associated with familial thoracic aortic aneurysms, the vascular Ehlers–Danlos gene COL3A1 and the MTHFR p.Ala222Val variant in 155 AAA patients. The thoracic aneurysm genes selected for this study were the transforming growth factor-beta pathway genes EFEMP2, FBN1, SMAD3, TGBF2, TGFBR1, TGFBR2, and the smooth muscle cells genes ACTA2, MYH11 and MYLK. Sanger sequencing of all coding exons and exon–intron boundaries of these genes was performed. Patients with at least one first-degree relative with an aortic aneurysm were classified as familial AAA (nxa0=xa099), the others as sporadic AAA. We found 47 different rare heterozygous variants in eight genes: two pathogenic, one likely pathogenic, twenty-one variants of unknown significance (VUS) and twenty-three unlikely pathogenic variants. In familial AAA we found one pathogenic and segregating variant (COL3A1 p.Arg491X), one likely pathogenic and segregating (MYH11 p.Arg254Cys), and fifteen VUS. In sporadic patients we found one pathogenic (TGFBR2 p.Ile525Phefs*18) and seven VUS. Thirteen patients had two or more variants. These results show a previously unknown association and overlapping genetic defects between AAA and familial thoracic aneurysms, indicating that genetic testing may help to identify the cause of familial and sporadic AAA. In this view, genetic testing of these genes specifically or in a genome-wide approach may help to identify the cause of familial and sporadic AAA.


American Journal of Medical Genetics Part A | 2009

Autosomal dominant inheritance of cardiac valves anomalies in two families: Extended spectrum of left-ventricular outflow tract obstruction

Marja W. Wessels; Ingrid M.B.H. van de Laar; Jolien W. Roos-Hesselink; Sipke Strikwerda; Danielle Majoor-Krakauer; Bert B.A. de Vries; Wilhelmina S. Kerstjens-Frederikse; Yvonne J. Vos; Bianca M. de Graaf; Aida M. Bertoli-Avella; Patrick J. Willems

Only a limited number of families with clear monogenic inheritance of nonsyndromic forms of congenital valve defects have been described. We describe two multiplex pedigrees with a similar nonsyndromic form of heart valve anomalies that segregate as an autosomal dominant condition. The first family is a three‐generation pedigree with 10 family members affected with congenital defects of the cardiac valves, including six patients with aortic stenosis and/or aortic regurgitation. Pulmonary and/or tricuspid valve abnormalities were present in three patients, and ventricular septal defect (VSD) was present in two patients. The second family consists of 11 patients in three generations with aortic valve stenosis in seven patients, defects of the pulmonary valves in two patients, and atrial septal defect (ASD) in two patients. Incomplete penetrance was observed in both families. Although left‐ventricular outflow tract obstruction was present in most family members, the co‐occurrence with pulmonary valve abnormalities and septal defects in both families is uncommon. These families provide evidence that left‐sided obstructive defects and thoracic aortic aneurysm may be accompanied by right‐sided defects, and even septal defects. These families might be instrumental in identifying genes involved in cardiac valve morphogenesis and malformation.


Journal of Vascular Surgery | 2013

Aneurysmal disease is associated with lower carotid intima-media thickness than occlusive arterial disease

Erik J. Bakker; Ellen V. Rouwet; Sanne E. Hoeks; Tabita M. Valentijn; Robert Jan Stolker; Danielle Majoor-Krakauer; Hence J.M. Verhagen

OBJECTIVEnPatients with aneurysmal and occlusive arterial disease have overlapping cardiovascular risk profiles. The question remains how atherosclerosis is related to the formation of aortic aneurysms. Common carotid artery intima-media thickness (CIMT) is an easily accessible and objective marker of early atherosclerosis. The aim of the current study was to investigate whether there is a difference in atherosclerotic burden as measured by CIMT between patients with aneurysmal and those with occlusive arterial disease.nnnMETHODSnFrom 2004 to 2011, the CIMT was measured using B-mode ultrasound scanning in patients undergoing vascular surgery for aortic aneurysmal or occlusive arterial disease at the Erasmus University Medical Center. Cardiovascular risk factors, comorbidities, and medication were recorded. Patients treated for combined aneurysmal and occlusive arterial disease and patients diagnosed with a genetic aneurysm syndrome were excluded. Univariable and multivariable analyses were used to calculate differences in CIMT between aneurysmal and occlusive arterial disease.nnnRESULTSnIn total, 904 patients were included in the study: 502 patients with aneurysmal disease (85% male; mean age, 72 years) and 402 patients with occlusive arterial disease (65% male; mean age, 64 years). The mean (standard deviation) CIMT in patients with aneurysmal disease was 0.97 (0.29) mm and was 1.07 (0.38) mm in patients with occlusive arterial disease (P < .001). Adjustment for cardiovascular risk factors, comorbidities, and medication showed a mean difference in CIMT of 0.15 mm (95% confidence interval, 0.10-0.20; P < .001).nnnCONCLUSIONSnThe current study shows a lower CIMT in patients with aneurysmal disease than in those with occlusive arterial disease, indicating a lower atherosclerotic burden in patients with aneurysmal disease. These findings endorse the idea that additional pathogenic mechanisms are involved in aortic aneurysm formation. Further studies are needed to clarify the role of atherosclerosis in aortic aneurysm formation.


Vascular Medicine | 2017

Risk of abdominal aortic aneurysm (AAA) among male and female relatives of AAA patients

Ellen V. Rouwet; Sanne E. Hoeks; Robert Jan Stolker; Hence J.M. Verhagen; Danielle Majoor-Krakauer

Sex affects the presentation, treatment, and outcomes of abdominal aortic aneurysm (AAA). Although AAAs are less prevalent in women, at least in the general population, women with an AAA have a poorer prognosis in comparison to men. Sex differences in the genetic predisposition for aneurysm disease remain to be established. In this study we investigated the familial risk of AAA for women compared to men. All living AAA patients included in a 2004–2012 prospective database were invited to the multidisciplinary vascular/genetics outpatient clinic between 2009 and 2012 for assessment of family history using detailed questionnaires. AAA risk for male and female relatives was calculated separately and stratified by sex of the AAA patients. Families of 568 AAA patients were investigated and 22.5% of the patients had at least one affected relative. Female relatives had a 2.8-fold and male relatives had a 1.7-fold higher risk than the estimated sex-specific population risk. Relatives of female AAA patients had a higher aneurysm risk than relatives of male patients (9.0 vs 5.9%, p = 0.022), corresponding to 5.5- and 2.0-fold increases in aneurysm risk in the female and male relatives, respectively. The risk for aortic aneurysm in relatives of AAA patients is higher than expected from population risk. The excess risk is highest for the female relatives of AAA patients and for the relatives of female AAA patients. These findings endorse targeted AAA family screening for female and male relatives of all AAA patients.


European Heart Journal | 2013

Arterial elongation and tortuosity leads to detection of a de novo TGFBR2 mutation in a young patient with complex aortic pathology

Frederico Bastos Gonçalves; Danielle Majoor-Krakauer; Hence J.M. Verhagen

In a 47-year-old muscular-build male admitted with acute abdominal pain imaging revealed a Stanford type-B aortic dissection associated with a pre-existing large aorto-iliac aneurysm ( Panels A and B ) and marked iliac-artery elongation and tortuosity ( Panels C and D , arrows). The patient underwent uneventful elective open repair of the aorto-iliac aneurysm. The marked aortic …


Brain | 2007

TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations

H. Seelaar; H. Jurgen Schelhaas; Asma Azmani; Benno Küsters; Sonia Rosso; Danielle Majoor-Krakauer; Maarten C. de Rijik; Patrizia Rizzu; Ming ten Brummelhuis; Pieter A. van Doorn; Wouter Kamphorst; Rob Willemsen; John C. van Swieten

Collaboration


Dive into the Danielle Majoor-Krakauer's collaboration.

Top Co-Authors

Avatar

Hence J.M. Verhagen

Erasmus University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Ellen V. Rouwet

Erasmus University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Robert Jan Stolker

Erasmus University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Sanne E. Hoeks

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Frederico Bastos Gonçalves

Erasmus University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Dennis Dooijes

Erasmus University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Marcel Kofflard

Albert Schweitzer Hospital

View shared research outputs
Top Co-Authors

Avatar

Michelle Michels

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Tabita M. Valentijn

Erasmus University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Aida M. Bertoli-Avella

Erasmus University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge